You are here

Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi Consumer Healthcare’s Road To Sustainability And B Corp Certification

Forbes

Wed, 09/13/23 - 11:19 am

Tags:

Sanofi, consumer health, sustainability

Madrigal's stock shaken with CEO change up, as Sanofi's Sibold takes the reins

Fierce Biotech

Tue, 09/12/23 - 10:34 am

Tags:

Madrigal Pharmaceuticals, Pharma CEOs, Sanofi, Bill Sibold, NASH

Sanofi appoints a venture investor to R&D head as executive team expands

BioPharma Dive

Thu, 08/31/23 - 06:05 pm

Tags:

Sanofi, R&D, Houman Ashrafian

US senators push drugmakers for details on low-cost insulin programs

Yahoo/Reuters

Thu, 08/31/23 - 10:11 am

Tags:

Senate, insulin, drug pricing, Novo Nordisk, Eli Lilly, Sanofi, diabetes

5 of the best places to work in pharma, according to employees

Pharma Voice

Tue, 08/29/23 - 11:32 am

Tags:

Glassdoor, Merck, JNJ, Pfizer, GSK, Sanofi

Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US

Clinical Trials Arena

Tue, 08/29/23 - 11:23 am

Tags:

Pfizer, AstraZeneca, Sanofi, Abrysvo, Beyfortus, RSV

Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial

BioSpace

Wed, 08/23/23 - 10:12 am

Tags:

Eli Lilly, Retevmo, thyroid cancer, medullary thyroid cancer, clinical trials, Exelixis, Capometyx, Sanofi, Caprelsa

10 clinical trials to watch in the second half of 2023

BioPharma Dive

Mon, 08/7/23 - 10:32 am

CDC advisers endorse RSV monoclonal antibody for infants, high-risk young children

Stat

Thu, 08/3/23 - 06:34 pm

Tags:

CDC, RSV, infants, monoclonal antibodies, Sanofi, Beyfortus

Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data

Fierce Biotech

Fri, 07/28/23 - 10:44 am

Tags:

Sanofi, BioNTech, MRNA, cytokines, cancer

Sanofi goes oral route in Recludix deal to develop tailored I&I drugs

Medical Marketing and Media

Fri, 07/21/23 - 10:12 am

Tags:

Sanofi, Recludix Pharma, inflammatory diseases, drug development

Scratching the surface of the urticaria pipeline

EP Vantage

Thu, 07/20/23 - 10:00 am

Tags:

chronic urticaria, Sanofi, Dupixent, Regeneron, Novartis, Roche, Xolair, Allakos, AstraZeneca, Celldex Therapeutics

CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus

Fierce Pharma

Tue, 07/18/23 - 10:06 pm

Tags:

CDC, Sanofi, AstraZeneca, RSV, Beyfortus

Sanofi expands research deal with gene editing startup Scribe

BioPharma Dive

Tue, 07/18/23 - 10:28 am

Tags:

Sanofi, gene editing, Scribe Therapeutics

FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants

BioSpace

Mon, 07/17/23 - 07:00 pm

Tags:

Sanofi, AstraZeneca, Beyfortus, nirsevimab, RSV, infants, pediatric, FDA

Dupixent goes back-to-back as top Rx, OTC pharma brand in June

Medical Marketing and Media

Thu, 07/6/23 - 10:16 am

Tags:

Dupixent, Sanofi, Regeneron

Sanofi blocks Sandoz's Jevtana generic in patent win

Fierce Pharma

Fri, 06/30/23 - 10:16 am

Tags:

Sanofi, Jevtana, generics, Sandoz, prostate cancer, legal

Sanofi outlines five-pronged approach to reel in €10B in vaccine sales by 2030

Fierce Pharma

Thu, 06/29/23 - 11:09 pm

Tags:

Sanofi, vaccines, R&D

Sanofi says it's back to the drawing board on mRNA flu vaccines

Reuters

Thu, 06/29/23 - 11:22 am

Tags:

Sanofi, vaccines, MRNA, flu vaccines, Flu

10 clinical trials to watch in the second half of 2023

BioPharma Dive

Wed, 06/28/23 - 11:44 am

Pages

last 30 twitter posts